Clinical research into the indications of PA-TACE after liver cancer surgery is currently focused mainly on postoperative tumor-related indicators such as MVI grade, tumor volume, tumor number, tumor differentiation, and Ki-67 (11, 17, 18). The gene discussed is MKI67; the disease is liver cancer.